Pharmaceutical preparations for use in the treatment of cancer and auto-immune diseases, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T-Cell therapy; T-cells for medical purposes; diagnostic kits consisting primarily of cells for medical laboratory use
REGISTERED
on 22 Dec 2021
ENHARNEX
CELGENE CORPORATION
1997108 · 04 Oct 2019
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use in the treatment of cancer and auto-immune diseases, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T-Cell therapy; T-cells for medical purposes; diagnostic kits consisting primarily of cells for medical laboratory use
Pharmaceutical preparations for use in the treatment of cancer and aut...
